Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Hirofumi, Niitsuma"'
Autor:
Kosuke Sato, Jun Inoue, Takehiro Akahane, Tomoo Kobayashi, Satoshi Takai, Takuya Nakamura, Toshihiro Sato, Osamu Kimura, Masashi Ninomiya, Tomoaki Iwata, Akitoshi Sano, Mio Tsuruoka, Masazumi Onuki, Satoko Sawahashi, Hirofumi Niitsuma, Atsushi Masamune
Publikováno v:
The Tohoku journal of experimental medicine. 258(4)
Nucleos(t)ide analogues (NAs) suppress hepatitis B virus (HBV) replication, but the risk of hepatocellular carcinoma still remains. The presence of detectable HBV DNA in the serum during NA therapies for chronic hepatitis B patients has been reported
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9278500fba1bd70645fabc4ee7a1bea7
https://pubmed.ncbi.nlm.nih.gov/36244758
https://pubmed.ncbi.nlm.nih.gov/36244758
Autor:
Jun, Inoue, Tomoo, Kobayashi, Takehiro, Akahane, Osamu, Kimura, Kosuke, Sato, Masashi, Ninomiya, Tomoaki, Iwata, Satoshi, Takai, Norihiro, Kisara, Toshihiro, Sato, Futoshi, Nagasaki, Masahito, Miura, Takuya, Nakamura, Teruyuki, Umetsu, Akitoshi, Sano, Mio, Tsuruoka, Masazumi, Onuki, Hirofumi, Niitsuma, Atsushi, Masamune, Therme Study Group
Publikováno v:
Journal of Clinical Medicine; Volume 11; Issue 9; Pages: 2354
Patients with a chronic hepatitis B virus (HBV) infection who are treated with nucleos(t)ide analogues (NAs) are still at risk for hepatocellular carcinoma (HCC), and it has been clinically questioned whether patients with a high risk of HCC can be i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89755ca8b104db49467c39e1b9d3d957
https://pubmed.ncbi.nlm.nih.gov/35566481
https://pubmed.ncbi.nlm.nih.gov/35566481
Autor:
Toshihiro Sato, Jun Inoue, Atsushi Masamune, Masaaki Izuma, Takuya Nakamura, Norihiro Kisara, Takehiro Akahane, Osamu Kimura, Hirofumi Niitsuma, Masashi Ninomiya, Akitoshi Sano, Tomoo Kobayashi, Tomoaki Iwata, Satoshi Takai, Haruo Nakayama, Eiji Kakazu, Tatsuki Morosawa
Publikováno v:
Hepatology Research. 49:1263-1274
Aim Hepatitis B virus genotype B (HBV/B) has been reported to have less risk of liver cirrhosis and hepatocellular carcinoma (HCC), but long-term observation has rarely been reported. We aimed to clarify the characteristics of HBV/B in nucleos(t)ide
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e9fafab29fedffb81c5c85bb7b880bcc
https://doi.org/10.1111/hepr.13398
https://doi.org/10.1111/hepr.13398
Autor:
Noriyuki Obara, Tooru Shimosegawa, Osamu Kimura, Yutaka Mano, Takeshi Yamamoto, Teruyuki Umetsu, Tomoo Kobayashi, Yu Nakagome, Tomoaki Iwata, Hirofumi Niitsuma, Takayuki Kogure, Masahito Miura, Yasuteru Kondo, Yasuyuki Fujisaka, Tatsuki Morosawa, Jun Inoue
Publikováno v:
Journal of Medical Virology. 88:69-78
It has been reported that acute hepatitis B (AHB) patients with genotype A HBV (HBV/A) have been increasing since the 1990s in metropolitan areas in Japan. However, little is known about the trends of HBV genotypes in AHB patients in northeast Japan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::736d35c39e4ba4982170678bd747a390
https://doi.org/10.1002/jmv.24309
https://doi.org/10.1002/jmv.24309
Autor:
Hirofumi, Niitsuma
Publikováno v:
Nihon rinsho. Japanese journal of clinical medicine. 73
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::da313771ffddd44daaaeb3807d320e10
https://pubmed.ncbi.nlm.nih.gov/26846012
https://pubmed.ncbi.nlm.nih.gov/26846012
Autor:
Hirofumi, Niitsuma
Publikováno v:
Nihon rinsho. Japanese journal of clinical medicine. 73
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::63115d056151342ba37c52aab452b5ab
https://pubmed.ncbi.nlm.nih.gov/26846013
https://pubmed.ncbi.nlm.nih.gov/26846013
Autor:
Toru Shimosegawa, Koji Fukushima, Yuta Wakui, Keiichi Tamai, Yoshiyuki Ueno, Jun Inoue, Masaaki Shiina, Yasuteru Kondo, Yoko Yamagiwa, Eiji Kakazu, Hirofumi Niitsuma, Noriyuki Obara, Takao Iwasaki
Publikováno v:
Journal of Viral Hepatitis. 18:206-215
Summary. To investigate the efficacy of long-term lamivudine (3TC) and adefovir dipivoxil (ADV) combination therapy in 3TC-resistant chronic hepatitis B virus (HBV) infected patients, we analysed 28 3TC-resistant patients treated with the combination
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f282681c4e2053a1727abdce2a64e7b4
https://doi.org/10.1111/j.1365-2893.2010.01301.x
https://doi.org/10.1111/j.1365-2893.2010.01301.x
Autor:
Hirofumi Niitsuma, Yuta Wakui, Yoshiyuki Ueno, Jun Inoue, Yasuteru Kondo, Koji Fukushima, Tooru Shimosegawa, Futoshi Nagasaki
Publikováno v:
Virology. 395(2):202-209
A plasmid carrying 1.3-fold HBV genome was constructed from a HBV strain that caused five consecutive cases of fulminant hepatitis (pBFH2), and HepG2 cells were transfected with pBFH2 or its variants. The pBFH2 construct with A1762T/G1764A, G1862T, a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0db6a669a3fa5c0b8bde67f060bf736e
Autor:
Jun, Inoue, Yasuteru, Kondo, Teruyuki, Umetsu, Takeshi, Yamamoto, Masahito, Miura, Yutaka, Mano, Tomoo, Kobayashi, Noriyuki, Obara, Hirofumi, Niitsuma, Takayuki, Kogure, Yu, Nakagome, Osamu, Kimura, Tomoaki, Iwata, Tatsuki, Morosawa, Yasuyuki, Fujisaka, Tooru, Shimosegawa
Publikováno v:
Journal of medical virology. 88(1)
It has been reported that acute hepatitis B (AHB) patients with genotype A HBV (HBV/A) have been increasing since the 1990s in metropolitan areas in Japan. However, little is known about the trends of HBV genotypes in AHB patients in northeast Japan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4c8d3fdfda4b68afa2936d73f96d85dc
https://pubmed.ncbi.nlm.nih.gov/26113372
https://pubmed.ncbi.nlm.nih.gov/26113372
Autor:
Tooru Shimosegawa, Eiji Kakazu, Koji Fukushima, Takeshi Yamamoto, Kumiko Kikuchi, Hirofumi Niitsuma, Takayuki Kogure, Noriatsu Kanno, Osamu Kido, Yu Nakagomi, Futoshi Nagasaki, Yasunori Matsuda, Yoko Yamagiwa, Yoshiyuki Ueno
Publikováno v:
The Tohoku Journal of Experimental Medicine. 210:29-36
Hepatitis B virus (HBV) infection, which causes liver cirrhosis and hepatocellular carcinoma, remains a major health problem in Asian countries. Recent development of vaccine for prevention is reported to be successful in reducing the size of chronic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43be10ecca122f77f02eb09b82d7dba4
https://doi.org/10.1620/tjem.210.29
https://doi.org/10.1620/tjem.210.29